New York · 2025 Regular Session · Bill
A 9252: Establishes a grant program to assist providers in purchasing opioid antagonists alongside automated external defibrillators
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
A 9252 is a bill introduced in the New York House on November 21, 2025. According to its official title, it concerns: Establishes a grant program to assist providers in purchasing opioid antagonists alongside automated external defibrillators. Primary sponsor: Landon Dais (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Establishes a grant program to assist providers in purchasing opioid antagonists alongside automated external defibrillators; establishes criteria for such grant program.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Landon Dais | Primary sponsor | Democratic | House | 77 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH
- REFERRED TO HEALTH